Tabetha Sundin PhD, HCLD, MB

Experience

• 

  Old Dominion University

  Jan 2011 - Mar 2013

  Research Assistant

  Post-doctoral research

• 

  Sentara Health

  Mar 2013 - Jul 2020

  Scientific Director

  Responsible for clinical and business oversight of the molecular diagnostics and serology laboratories. Responsibilities include budgeting, contract negotiation, clinical instrumentation assessment and validation, CAP accreditation and staff development.

• 

  AstraZeneca

  Jan 2017 - now

  Trained speaker for Tagrisso.

  • Head of Diagnostics, Global Medical OBU

    Jul 2022 - now

  • Sr. Global Medical Affairs Lead, Diagnostics I-O

    Jul 2020 - Jul 2022

  • Women’s Oncology Commercial Diagnostics Speaker Bureau

    Aug 2018 - Jul 2020

  • Pathology Speaker Bureau Member

    Jan 2017 - Jul 2020
• 

  Bristol Myers Squibb

  Jul 2018 - Jul 2020

  • Unbranded Biomarker Steering Committee

    Aug 2018 - Jul 2020

  • I-O Speaker

    Jul 2018 - Jul 2020
• 

  Old Dominion University

  Aug 2019 - now

  Adjunct Associate Professor
• 

  American Society for Clinical Pathology (ASCP)

  Nov 2019 - Jul 2020

  Lablogatory Scientist Writer
• 

  Clinical Lab Advisor

  May 2020 - Jun 2020

  Lab Advisor

  Consultant with experience in clinical serology and molecular diagnostics including NGS, PCR, and Sanger Sequencing.Contact me at go.clinicallabadvisor.com/tabetha_sundin